Literature DB >> 11237327

Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography.

D Harada1, S Naito, Y Kawauchi, K Ishikawa, O Koshitani, I Hiraoka, M Otagiri.   

Abstract

A high-performance liquid chromatographic assay was developed for the quantitative determination of the sulfur-containing amino acids N-acetyl-L-cysteine (NAC) and L-cysteine (Cys) in rat plasma. The thiols were separated by reverse-phase ion-pair chromatography, and the column eluent was continuously mixed with an iodoplatinate-containing solution. The substitution of sulfur of the thiol compound with iodide was quantitatively determined by measuring changes in the absorption at 500 nm. The low-molecular-weight disulfides and mixed disulfide conjugates of thiols with proteins were entirely reduced to the original reduced compounds by dithiothreitol. By reducing these two types of disulfides separately during sample pretreatment, the reduced, protein-unbound, and total thiol concentrations could also be determined. Validation testing was performed, and no problems were encountered. The limit of detection was approximately 20 pmol of thiol on the column. The present method was used to measure the plasma concentrations of NAC and Cys in the rat after a bolus intravenous administration of NAC, focusing on disulfide formation. The binding of NAC to protein through mixed disulfide formation proceeds in a time-dependent and reversible manner. Moreover, this "stable" covalent binding might limit total drug elimination, while the unbound NAC is rapidly eliminated. Consequently, the analytical method described in this study is very useful for the determination of plasma NAC and Cys, including disulfide conjugates derived from them. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237327     DOI: 10.1006/abio.2000.4980

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.

Authors:  Fanuel T Hagos; Monica J Daood; Jacob A Ocque; Thomas D Nolin; Hulya Bayir; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey
Journal:  Xenobiotica       Date:  2016-06-09       Impact factor: 1.908

2.  Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine.

Authors:  Takeji Saitoh; Hiroshi Satoh; Mamoru Nobuhara; Masashi Machii; Takamitsu Tanaka; Hayato Ohtani; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

3.  Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro.

Authors:  Daisuke Harada; Shinsuku Naito; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

4.  In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats.

Authors:  Daisuke Harada; Shinsaku Naito; Isao Hiraoka; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

5.  Flow injection spectrophotometric determination of N-acetyl-L-cysteine as a complex with palladium(II).

Authors:  Josipa Giljanović; Mia Brkljača; Ante Prkić
Journal:  Molecules       Date:  2011-08-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.